Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: Effects of complexation with copper(II), gallium(III), and iron(III) on their antiproliferative activities

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 2061-2063

  Richardson, D R ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ION; FERRIC ION; GALLIUM; PYRIDOXAL ISONICOTINOYLHYDRAZONE;

ARTICLE; CANCER; COMPLEX FORMATION; DNA SYNTHESIS; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030868750     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.2061     Document Type: Article

References (18)

1. Becton, D. L., and P. Bryles. 1988. Deferoxamine inhibition of human neuroblastoma viability and proliferation. Cancer Res. 48:7189-7192.
2. Becton, D. L., and B. Roberts. 1989. Antileukemic effects of deferoxamine on human myeloid leukemia cell lines. Cancer Res. 49:4809-4812.
3. Burger, R. M., J. Peisach, and S. B. Horwitz. 1981. Activated bleomycin: a transient complex of drug, iron, and oxygen that degrades DNA. J. Biol. Chem. 256:11636-11644.
4. Donfrancesco, A., G. Deb, C. Dominici, D. Pileggi, M. A. Castello, and L. Helson. 1990. Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res. 50:4929-1930.
5. Edward, J. T., M. Gauthier, F. L. Chubb, and P. Ponka. 1988. Synthesis of new acylhydrazones as iron chelating compounds. J. Chem. Eng. Data 33: 538-540.
6. Estrov, Z., A. Tawa, X.-H. Wang, I. D. Dube, H. Sulh, A. Cohen, E. W. Gelfand, and M. H. Freedman. 1987. In vivo and in vitro effects of desferrioxamine in neonatal acute leukemia. Blood 69:757-761.
7. Johnson, D. K., T. B. Murphy, N. J. Rose, W. H. Goodwin, and L. Pickart. 1982. Cytotoxic chelators and chelates. 1. Inhibition of DNA synthesis in cultured rodent and human cells by aroylhydrazones and by a copper(II) complex of salicylaldehyde benzoyl hydrazone. Inorg. Chim. Acta 67:159-165.
8. Kontoghiorghes, G. J., A. Piga, and A. V. Hoffbrand. 1986. Cytotoxic effects of the lipophilic iron chelator omadine. FEBS Lett. 204:208-212.
9. Richardson, D. R., and E. Baker. 1990. The uptake of iron and transferrin by the human melanoma cell. Biochim. Biophys. Acta 1053:1-12.
10. Richardson, D. R., G. T. Hefter, P. M. May, J. Webb, and E. Baker. 1989. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II). Biol. Metals 2:161-167.
11. Richardson, D. R., and K. Milnes. 1997. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective anti-proliferative agents. II. The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Blood 89:3025-3038.
12. Richardson, D. R., and P. Ponka. 1994. The iron metabolism of the human neuroblastoma cell. Lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis. J. Lab. Clin. Med. 124:660-671.
13. Richardson, D. R., E. Tran, and P. Ponka. 1995. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Blood 86:4295-4306.
14. Richardson, D. R., M. L. Wis Vitolo, G. T. Hefter, P. M. May, B. W. Clare, and J. Webb. 1990. Iron chelators of the pyridoxal isonicotinoyl hydrazone class part 1. Ionisation characteristics of the ligands and their relevance to biological properties. Inorg. Chim. Acta 170:165-170.
15. Seligman, P. A., R. B. Schleicher, G. Siriwardana, J. Domenico, and E. W. Gelfand. 1993. Effects of agents that inhibit cellular iron incorporation on bladder cell proliferation. Blood 82:1608-1617.
16. Singh, S., and R. C. Hider. 1988. Colorimetric detection of the hydroxyl radical: comparison of the hydroxyl radical generating ability of various iron complexes. Anal. Biochem. 171:47-54.
17. Thelander, L., and A. Gräslund. 1983. Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. J. Biol. Chem. 258:4063-4066.
18. Vitolo, L. M. W., G. T. Hefter, B. W. Clare, and J. Webb. 1990. Iron chelators of the pyridoxal isonicotinoyl hydrazone class part 2. Formation constants with iron(III) and iron(II). Inorg. Chim. Acta 170:171-176.